Hormonal Variations (hormonal + variation)

Distribution by Scientific Domains


Selected Abstracts


Common genetic influences underlie comorbidity of migraine and endometriosis

GENETIC EPIDEMIOLOGY, Issue 2 2009
Dale R. Nyholt
Abstract We examined the co-occurrence of migraine and endometriosis within the largest known collection of families containing multiple women with surgically confirmed endometriosis and in an independent sample of 815 monozygotic and 457 dizygotic female twin pairs. Within the endometriosis families, a significantly increased risk of migrainous headache was observed in women with endometriosis compared to women without endometriosis (odds ratio [OR] 1.57, 95% confidence interval [CI]: 1.12,2.21, P=0.009). Bivariate heritability analyses indicated no evidence for common environmental factors influencing either migraine or endometriosis but significant genetic components for both traits, with heritability estimates of 69 and 49%, respectively. Importantly, a significant additive genetic correlation (rG = 0.27, 95% CI: 0.06,0.47) and bivariate heritability (h2=0.17, 95% CI: 0.08,0.27) was observed between migraine and endometriosis. Controlling for the personality trait neuroticism made little impact on this association. These results confirm the previously reported comorbidity between migraine and endometriosis and indicate common genetic influences completely explain their co-occurrence within individuals. Given pharmacological treatments for endometriosis typically target hormonal pathways and a number of findings provide support for a relationship between hormonal variations and migraine, hormone-related genes and pathways are highly plausible candidates for both migraine and endometriosis. Therefore, taking into account the status of both migraine and endometriosis may provide a novel opportunity to identify the genes underlying them. Finally, we propose that the analysis of such genetically correlated comorbid traits can increase power to detect genetic risk loci through the use of more specific, homogenous and heritable phenotypes. Genet. Epidemiol. 2008. © 2008 Wiley-Liss, Inc. [source]


Gingival changes during pregnancy: I. Influence of hormonal variations on clinical and immunological parameters

JOURNAL OF CLINICAL PERIODONTOLOGY, Issue 3 2010
Elena Figuero
Figuero E, Carrillo-de-Albornoz A, Herrera D, Bascones-Martínez A. Gingival changes during pregnancy: I. Influence of hormonal variations on clinical and immunological parameters. J Clin Periodontol 2009; 37: 220,229. doi: 10.1111/j.1600-051X.2009.01516.x. Abstract Aim: To test whether exacerbated gingival inflammation in pregnancy is associated with increased salivary hormone levels and changes in gingival crevicular fluid (GCF) interleukin-1, (IL-1,) and prostaglandin-E2 (PGE2) levels. Material and methods: In this cohort study, 48 pregnant women without periodontitis were evaluated in the first, second, and third trimesters and at 3 months postpartum. Twenty-eight non-periodontitis non-pregnant women were evaluated twice, with a 6-month interval. Plaque and gingival indices (PlI, GI), salivary progesterone and estradiol and GCF IL-1, and PGE2 levels were determined. anova for repeated measures or Friedman's test were used for intragroup analyses. Inter-group comparisons were analysed with t -test or Mann,Whitney U -test. Correlations were evaluated with Pearson's and Spearman's test. Results: Pregnant women showed an increase in GI (p<0.05) despite maintaining low PlI values. No changes in IL-1, and PGE2 levels were observed during pregnancy. No significant correlation was found between the GI increase and salivary hormone levels. GI (p<0.05) and IL-1, levels (p<0.001) were lower in non-pregnant than in pregnant women. Conclusions: This study confirms the presence of an exacerbated gingival inflammation during pregnancy, but this phenomenon could not be associated with an increase in progesterone or estradiol or with changes in PGE2 or IL-1,. [source]


Gingival changes during pregnancy: II.

JOURNAL OF CLINICAL PERIODONTOLOGY, Issue 3 2010
Influence of hormonal variations on the subgingival biofilm
Carrillo-de-Albornoz A, Figuero E, Herrera D, Bascones-Martínez A. Gingival changes during pregnancy: II. Influence of hormonal variations on the subgingival biofilm. J Clin Periodontol 2010; 37: 230,240. doi: 10.1111/j.1600-051X.2009.01514.x. Abstract Aim: To determine whether the exacerbated gingival inflammation that develops in pregnant women is related to a change in the subgingival biofilm induced by the increase in hormone levels during pregnancy. Material and Methods: This open cohort study included 48 pregnant and 28 non-pregnant women without periodontitis. Pregnant women were evaluated in the first, second and third trimester and at 3 months after delivery. Non-pregnant women were evaluated twice, with a 6-month interval, assessing microbiological, clinical and hormonal variables at each visit. Total anaerobic counts and frequency of detection and proportions were calculated. The Friedman test with the Bonferroni correction was used for intra-group comparisons and Mann,Whitney U -tests for inter-group assessment. Correlations were analysed by means of Spearman's rank correlation coefficient. Results: Proportions of the subgingival periodontal pathogens did not differ throughout pregnancy, although significant differences were found for all the pathogens after delivery. Porphyromonas gingivalis -positive patients presented an increase in gingival inflammation (p<0.001) that was not related to plaque. Correlations were found between maternal hormone levels and P. gingivalis and Prevotella intermedia. Conclusion: Qualitative differences in periodontal pathogens were found from pregnancy to post-partum. Patients harbouring P. gingivalis presented and increased gingival inflammatory status. [source]


Menstrual cycle influences ocular surface parameters in normal and dry eye patients

ACTA OPHTHALMOLOGICA, Issue 2007
P VERSURA
Purpose: We analyzed the changes of ocular surface parameters and symptoms in healthy and dry eye women over the menstrual cycle. To our knowledge, incomplete reports appear in the literature on this issue in healthy women still in the fertile period, and none on dry eye women of the same age. This to comparatively evaluate what then happens in peri- and post-menopause. Methods: 29 females in the fertile age and a regular 26-29 days menstrual cycle were included in the study. 14 subjects with and 15 without dry eye symptoms. Symptoms were scored by the validate questionnaire OSDI. Degree of dryness was evaluated with the Schirmer test I, Jones test, BUT, Ferning test, Tear Function Index (TFI) and conjunctival imprint cytology. Degree of inflammation was evaluated with conjunctival brush cytology and dosage of exudated serum albumin in tears. Hormonal cytology procedures were applied to exfoliated cells in tears. Patients were analysed during menstruation, in the follicular and in luteal phases over two consecutive cycles and results were statistically evaluated Results: TFI, tear stability, surface dryness and inflammation were significantly related to the hormonal fluctuations in menstrual cycle, in particular to the estrogen peak occurring during the follicular phase, especially in dry eye patients. Subjective symptoms appeared to increase in the luteal phase, suggesting the presence of a pre-menstrual syndrome Conclusions: The ocular surface is confirmed to be dependent from hormonal variations; clinicians would take into account these cyclic variations during the examinations of subjects still in the fertile age, with dryness symptoms [source]